David Shaw’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

David Shaw’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,216	Closed	-$9.3K	–	5149
2022 Q4	$9.3K	Hold	37,216	–	–	﹤0.01%	4618
2022 Q3	$4K	Hold	37,216	–	–	﹤0.01%	5056
2022 Q2	$6K	Hold	37,216	–	–	﹤0.01%	5216
2022 Q1	$7K	Hold	37,216	–	–	﹤0.01%	5446
2021 Q4	$22K	Hold	37,216	–	–	﹤0.01%	5291
2021 Q3	$21K	Buy	37,216 +26,105	+235%	+$20.3K	﹤0.01%	4892
2021 Q2	$11K	Buy	+11,111	New	+$10.3K	﹤0.01%	4717

David Shaw's EBACW Position: Q1 2023 in Review

David Shaw sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 37,216 shares — an estimated $9.3K sold.

David Shaw first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $22K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

David Shaw reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
David Shaw sold 37,216 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $9.3K.
David Shaw first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
David Shaw's European Biotech Acquisition Corp. Warrant position peaked at $22K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.